|
Table 1. Malignant Tumors at the
Site of Total Hip Arthroplasty |
|||||||
|
Reference |
Age (y) |
Sex |
Post-op
(y) |
Histopathology |
Implant
type |
Ball |
Cup |
|
Aboulafia40 |
63 |
F |
2 |
MFH |
NR |
Cr |
PE |
|
Adams41 |
62 |
M |
3 |
Osteosarcoma |
Zimmer
Harris-Galante |
CoCr |
PE |
|
Arden
and Bywater39 |
56 |
NR |
2.5 |
Fibrosarcoma |
McKee-Farrar |
CoCr |
CoCr |
|
Bago-Granell42 |
77 |
F |
2 |
MFH |
Charnley-Muller |
NR |
NR |
|
Bell43 |
62 |
F |
4 |
MFH |
NR |
CoCr |
PE |
|
Bower44 |
NR |
NR |
NR |
Osteosarcoma |
NR |
NR |
NR |
|
Brien45 |
60 |
F |
8 |
Osteosarcoma |
Charnley |
SS |
PE |
|
Cole46 |
61 |
F |
2 |
MFH |
Cementless
bipolar hemiarthroplasty with a titanium prothesis (Premier Bipolar
Prosthesis), revision hybrid total hip replacement using
cobalt-chrome-molybdenum components (RX-90) (16 mo later) |
CoCr |
PE |
|
Ganapathi47 |
85 |
F |
12 |
NHL |
NR |
NR |
NR |
|
Goodfellow48 |
59 |
M |
9 |
Pleomorphic
rhabdomyosarcoma |
Christiansen |
NR |
Polyacetal |
|
Goodfellow48 |
64 |
M |
10 |
Poorly
differentiated spindle cell sarcoma |
Charnley |
SS |
PE |
|
Haag49 |
69 |
F |
10 |
MFH |
Weber-Huggler |
CoCr |
PE |
|
Harris50 |
70 |
F |
3 |
Chondrosarcoma |
Charnley |
SS |
PE |
|
Ito51 |
80 |
F |
8 |
NHL |
Charnley |
SS |
PE |
|
Jacobs52 |
65 |
M |
0.5 |
MFH |
AML |
Cr |
PE |
|
Keel53 |
73 |
F |
2.5 |
Osteosarcoma |
NR |
NR |
NR |
|
Keel53 |
50 |
M |
2.5 |
MFH |
NR |
NR |
NR |
|
Keel53 |
85 |
M |
7 |
Malignant
peripheral nerve sheath tumor |
NR |
NR |
NR |
|
Keel53 |
75 |
M |
5 |
MFH |
NR |
NR |
NR |
|
Keel53 |
68 |
M |
3 |
Osteosarcoma |
NR |
TiAlV |
NR |
|
Keel53 |
61 |
M |
6.5 |
MFH |
NR |
CoCr |
NR |
|
Lamovec54 |
50 |
M |
12 |
Synovial
sarcoma |
Charnley-Muller |
SS |
PE |
|
Lamovec54 |
65 |
F |
10 |
Osteosarcoma |
Charnley-Muller |
SS |
PE |
|
Langkamer55 |
77 |
F |
3 |
Leiomyosarcoma |
Muller |
NR |
NR |
|
Langkamer55 |
75 |
M |
2 |
MFH |
Muller |
SS |
PE |
|
Langkamer55 |
77 |
F |
20 |
Leiomyosarcoma |
Cemented
THA |
NR |
PE |
|
Langkamer55 |
69 |
F |
2 |
MFH |
Charnley |
SS |
NR |
|
Lightowler48 |
64 |
M |
10 |
Poorly
differentiated spindle cell sarcoma |
Charnley |
NR |
NR |
|
Martin56 |
66 |
F |
11 |
Osteosarcoma |
Charnley-Muller |
CoCr |
PE |
|
Mathiesen57 |
74 |
F |
15 |
MFH |
Charnley-Muller |
NR |
PE |
|
Nelson58 |
72 |
F |
10 |
MFH |
Muller |
Cr |
PE |
|
Penman34 |
75 |
F |
5 |
Osteosarcoma |
Ring |
CoCr |
CoCr |
|
Prasad59 |
70 |
M |
6.5 |
Osteosarcoma |
Howse II |
TiAlV |
PE/Ti
backed |
|
Rana60 |
66 |
F |
13 |
Spindle
cell sarcoma |
Howse I |
SS |
PE |
|
Radhi61 |
63 |
F |
4 |
NHL |
PCA |
CoCr |
PE |
|
Rees48 |
88 |
F |
3 |
MFH |
Thompson |
NR |
NR |
|
Rock62 |
79 |
M |
8 |
MFH |
PCA |
CoCr |
PE |
|
Rushforth38 |
54 |
F |
0.5 |
Osteosarcoma |
McKee-Farrar |
CoCr |
CoCr |
|
Ryu36 |
40 |
M |
1.5 |
Fibrosarcoma |
Ceramic |
CoCrAlO |
AlO |
|
Shaw63 |
77 |
M |
2 |
Multiple
myeloma |
Charnley |
NR |
NR |
|
Schmidt64 |
50 |
F |
2 |
Adenocarinoma |
NR |
NR |
PE |
|
Schuh65 |
66 |
F |
8 |
MFH |
Jorgensen |
NR |
NR |
|
Solomon
and Sekal66 |
48 |
F |
7 |
MFH |
Charnley-Muller |
NR |
NR |
|
Stephensen37 |
57 |
M |
6 |
Liposarcoma |
Protek
Harris-Galante |
CoCr |
Titanium
shell with 3 TiAlV screws |
|
Surin48 |
59 |
M |
9 |
Pleomorphic
rhabdomyosarcoma |
Charnley |
NR |
NR |
|
Swann35 |
63 |
M |
3.5 |
MFH |
McKee-Farrar |
CoCr |
CoCr |
|
Syed67 |
75 |
F |
8 |
NHL |
|
SS |
PE |
|
Tait68 |
56 |
F |
11 |
MFH |
Charnley-Muller |
PE |
NR |
|
Troop69 |
39 |
M |
15 |
MFH |
Charnley-Muller,
Aufranc-Turner (2 yrs later), Aufranc-Turner (3 mo later),
Sivash-Russin-Noiles (1.5 yrs later) |
TiAlV |
PE |
|
van der
List70 |
72 |
F |
12 |
Malignant
epithelioid hemangioma |
Charnley-Muller |
Cr |
PE |
|
NR
indicates not reported; MFH, malignant fibrous histiocytoma; NHL, non-Hodgkin
lymphoma |
|||||||